Date published: 2025-10-10

00800 4573 8000

SCBT Portrait Logo
Seach Input

UBE2U Aktivatoren

UBE2U,or "Ubiquitin-Conjugating Enzyme E2 U," is a protein that in humans is encoded by the UBE2U gene. This enzyme is a member of the ubiquitin-conjugating (E2) enzyme family, playing a crucial role in the ubiquitination pathway, a fundamental process for protein degradation and regulation within the cell.Ubiquitination is a process where ubiquitin, a small regulatory protein, is attached to substrates, typically signaling them for degradation via the proteasome or altering their cellular location, activity, or interactions. UBE2U functions as an E2 enzyme, which is responsible for the transfer of ubiquitin from the E1 activating enzyme to specific substrates, often with the assistance of an E3 ubiquitin ligase.The specific substrates and biological functions of UBE2U are still under research, but given the general importance of ubiquitination in cellular regulation, it is likely involved in multiple critical cellular processes. This can include cell cycle regulation, DNA repair, and response to stress or external stimuli.

UBE2U's role in ubiquitination suggests its involvement in various disease pathways, particularly those where protein degradation and regulation are disrupted, such as in cancer, neurodegenerative disorders, and inflammatory conditions. Abnormalities in ubiquitination processes are linked to the pathogenesis of these diseases, highlighting the significance of enzymes like UBE2U in maintaining cellular homeostasis.In summary, UBE2U is an important component of the ubiquitination pathway, with roles in various cellular processes and disease mechanisms. As such, it remains a subject of active research in the field of molecular biology and biochemistry.

Siehe auch...

ProduktCAS #Katalog #MengePreisReferenzenBewertung

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

Der Proteasom-Inhibitor MG132 kann den Ubiquitin-Proteasom-Weg beeinflussen und damit möglicherweise die Funktion von UBE2U beeinträchtigen.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Ein weiterer Proteasom-Inhibitor, Bortezomib, könnte UBE2U indirekt beeinflussen, indem er die Wege des Proteinabbaus beeinflusst.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

Lactacystin ist ein spezifischer Inhibitor des Proteasoms und kann Ubiquitinierungsprozesse modulieren, was sich möglicherweise auf UBE2U auswirkt.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

PYR-41, ein Inhibitor des Ubiquitin-aktivierenden Enzyms E1, könnte indirekt die Aktivität von UBE2U im Ubiquitinierungsweg beeinflussen.

DBeQ

177355-84-9sc-499943
10 mg
$330.00
1
(0)

Hemmt USP14, ein deubiquitinierendes Enzym, das möglicherweise die Ubiquitinierungswege beeinflusst, an denen UBE2U beteiligt ist.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Moduliert die Wege des Proteinabbaus, könnte indirekte Auswirkungen auf die Aktivität von UBE2U haben.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$49.00
$367.00
$2030.00
18
(1)

Ein immunmodulatorisches Medikament, das die Proteinhomöostase und möglicherweise die Funktion von UBE2U beeinflussen kann.

Pomalidomide

19171-19-8sc-364593
sc-364593A
sc-364593B
sc-364593C
sc-364593D
sc-364593E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$98.00
$140.00
$306.00
$459.00
$1224.00
$1958.00
1
(1)

Ähnlich wie Thalidomid beeinflusst es die Wege des Proteinabbaus, was sich möglicherweise auf UBE2U auswirkt.